The Effect of Probiotic and Zinc Supplementation in Patients With Gastroesophageal Reflux Disease

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

October 1, 2025

Conditions

Gastro-oesophageal Reflux Disease

Interventions

DRUG

PPI (proton pump inhibitor)

It reduces stomach acid production and manage GERD symptoms

DRUG

Probiotic

Live microorganisms, primarily bacteria and yeast, that are believed to provide health benefits when consumed in adequate.

DRUG

Zinc

Zinc used a supplement due to its role in decreasing inflammation of the gastroesophageal reflux disease.

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT06664008 - The Effect of Probiotic and Zinc Supplementation in Patients With Gastroesophageal Reflux Disease | Biotech Hunter | Biotech Hunter